To block protein-antibody complex formation during immunochemical analysis of NAPE-PLD
Related Products
Applicable for Use with
10305NAPE-PLD (Internal) Polyclonal Antibody
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

NAPE-PLD Blocking Peptide (aa 159-172)

Item No. 10303

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formulation (Request formulation change)
200 µg of peptide lyophilized from from 200 µl water
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    200 µg

    $146

    Add
    Product Description

    To be used in conjunction with Cayman’s NAPE-PLD (Internal) Polyclonal Antibody (Item No. 10305) to block protein-antibody complex formation during analysis of NAPE-PLD. N-Acylethanolamines (NAEs) are involved in diverse biological processes such as inflammatory regulation, apoptosis, and tissue degeneration.1 In animals, NAEs are mainly biosynthesized via a membrane phospholipid-dependent pathway, which is the enzymatic hydrolysis of N-acyl-phosphatidylethanolamine (NAPE). The enzyme catalyzing this reaction is a phospholipase D (PLD) subtype selective for NAPE named N-acylphosphatidylethanolamine-hydrolysing PLD (NAPE-PLD). It has been cloned from mouse, rat, and human and is 393-396 amino acids in length, with an estimated molecular weight of 46 kDa. Both NAPE-PLD mRNA and protein activity have been detected in a wide range of tissues with the highest levels in brain, kidney, and testis.2 In rat, NAPE-PLD activity in the brain is low in neonates and is 15-fold higher in adults, whereas the activity remains constant in the heart during development.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Hansen, H.S., Moesgaard, B., Petersen, G., et al. Putative neuroprotective actions of N-acyl-ethanolamines. Pharmacol. Ther. 95(2), 119-126 (2002).

    2. Okamoto, Y., Morishita, J., Tsuboi, K., et al. Molecular characterization of a phospholipase D generating anandamide and its congeners. The Journal of Biological Chemisty 279(7), 5298-5305 (2004).

    3. Moesgaard, B., Petersen, G., Jaroszewski, J.W., et al. Age dependent accumulation of N-acyl-ethanolamine phospholipids in ischemic rat brain: A 31P NMR and enzyme activity study. J. Lipid Res. 41(6), 985-990 (2000).